Answers are grounded in this paper and cite their sources.
Maternal mortality is on the rise, and around 33% of all pregnancy-related deaths are due to cardiovascular (CV) complications. Insults during gestation, particularly those arising from a disrupted maternal hormonal milieu, can be detrimental to the CV system. For instance, gestational hyperandrogenism observed in preeclampsia and polycystic ovary syndrome has been tied to heightened maternal CV risk across pregnancy and extending into the postpartum period. However, the mechanisms by which hyperandrogenism compromises the maternal CV system are still poorly understood. Using a well-validated sheep model of hyperandrogenism, we have previously reported increased cardiomyocyte apoptosis, fibrosis, and inflammation in postpartum ewes of gestational testosterone (T) excess. However, whether the postpartum pathological cardiac outcomes represent persistence of adverse cardiac remodeling programmed during gestation is unknown. We hypothesize that excess testosterone (T) during mid-gestation will lead to adverse maternal cardiac remodeling in late gestational ewes. From gestation day (GD) 30-90 (full term GD147), pregnant ewes were injected with 100 mg of testosterone intramuscularly twice weekly. On GD 120, maternal body weight (BW), cardiac left ventricle (LV), and right ventricle (RV) weights were measured, and LV tissue was processed for histological and molecular analyses. Data was analyzed by Student’s t-test and Cohen’s effect size (d) analysis. BW, Heart/BW, LV/BW, and RV/BW were similar between T-treated and control (C) ewes. Masson Trichrome analysis revealed increased LV collagen deposition in T-treated than C ewes (p=0.0003). T treatment also downregulated expression of Transforming Growth Factor Beta 1 Receptor 1 (TGFβ1-R1), a central mediator of fibrosis, relative to C (p=0.03), indicating a potentially compensatory effect. Furthermore, Oil Red O staining revealed increased LV lipid deposition in the T-treated ewes vs C (p=0.002). Gene expression of Diacylglycerol Acyltransferase (DGAT), a key protein involved in fatty acid and triglyceride synthesis, was downregulated in T-treated vs C (p=0.01). Functionally, echocardiogram measurements demonstrated fractional area (FxArea) had a non-significant large effect size increase in T-treated LV compared to C (d=0.89), while left ventricular internal diameter (LVIDs) (Cohen’s d=0.95) and cardiac output (Cohen’s d=1.2) had a large effect size decrease in T-treated ewes compared to C. Together, elevation in lipid content, collagen deposition, and altered functional parameters point to adverse cardiac remodeling in late gestation that likely persists contributing to the postpartum cardiac dysfunctions reported earlier in this model. Such persistence in adverse maternal cardiac remodeling is concerning for irreversible long-term detrimental maternal cardiac outcomes. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
Dantam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: